6118 — Austar Lifesciences Share News
0.000.00%
- HK$317.80m
- HK$388.81m
- CNY1.53bn
Brief: Austar Lifesciences Says Unit Completed Acquisition Of Technology And Ancillary Business Of Nanjing Bojian Technology Co.
Brief: Austar Lifesciences Sees Profit Attributable Of Not Less Than RMB270 Mln For Year
Brief: EPI (Holdings) Disposed 280,000 Austar Lifesciences Shares On Open Market For HK$5.1 Million
Brief: Austar Lifesciences Posts HY Profit Attributable RMB217.9 Mln Vs RMB12.8 Mln
Brief: Austar Lifesciences Sees Profit Attributable Of Not Less Than Rmb200 Million For Six Months
HK-listed Austar Lifesciences sees worst day in over 6 months
Brief: Austar Lifesciences Updates On Disposal Of 60% Interest In Pall-Austar JV
Brief: Austar Lifesciences Expects Profit Attributable In Range Of RMB30 Mln To RMB40 Mln For Year
Brief: Austar Lifesciences Says Unit To Engage Contractor For New Songjiang Facility For Rmb113.7 Mln
Brief: Austar Lifesciences Says Shanghai Austar Shall Receive An Aggregate Sum Of Rmb92.3 Mln
Brief: Austar Lifesciences Sees FY Profit Attributable Of No Less Than About Rmb8 MLN
Brief: Austar Lifesciences Sees Turnaround To Profit Attributable For Six Months
Brief: Austar Lifesciences Announces Formation Of Joint Venture
Brief: Austar Lifesciences Says Unit Enters Investment Agreement With H+E GmbH To Form JV In Germany
Brief: Austar Lifesciences Sees Substantial Decrease In Loss For Year Ending Dec 31
Brief: Austar Lifesciences Says Unit Won Public Tender For Land Use Right
Brief: Austar Lifesciences HY Loss Attributable Narrows
Brief: Austar Lifesciences Says Group Expects Decrease In HY Loss Attributable
Brief: Austar Lifesciences Posts FY Revenue RMB546.9 Mln